Reports
-
Providing antiretroviral therapy for mobile populations: Lessons learned from a cross border ARV programme in Musina, South Africa
Migrant populations are especially vulnerable to HIV and TB. They are at higher risk of infection, face challenges in accessing care, and have a higher risk of poor adherence, treatment interruption,...
Last updated 23 July 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1867 -
Undetectable: How Viral Load Monitoring Can Improve HIV Treatment in Developing Countries
Today, eight million people in developing countries have access to HIV therapy and while many more need to be reached with life-saving medicines, this is important progress. However, the monitoring that...
Last updated 23 July 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1866 -
Fighting Neglect
"Fighting Neglect" charts MSF's 25 years of experience in diagnosing and treating Chagas disease, sleeping sickness, and kala azar, in Latin America, Sub-Saharan Africa, South Asia and the Caucasus.
Last updated 11 June 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1855 -
Financing Medical Innovation Through Alternative Mechanisms
How to boost R&D for a low-cost, point-of-care rapid diagnostic test and better drugs for tuberculosis On 11 April 2008, Médecins Sans Frontières (MSF) convened a one-day consultation of tuberculosis...
Last updated 11 April 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/1830 -
From the ground up: Building a drug-resistant TB programme in Uganda
Uganda is one of the world's 22 high burden countries for tuberculosis (TB). Despite having a national treatment programme for drug-sensitive TB, there has been an emergence of drug-resistant strains...
Last updated 23 April 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1825 -
The Right Shot: Extending the reach of affordable and adapted vaccines
Lack of information on both the price and the different product characteristics of vaccines has been limiting countries’ ability to operate affordable and effective immunisation programmes.
Last updated 10 April 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1815 -
Antiretroviral Sequencing Meeting Report
MSF, Solidarité thérapeutique hospitalière en réseau (Esther), Solidarité thérapeutique contre le sida (SOLTHIS) convened a meeting in September 2011 of HIV treatment experts to look at antiretroviral...
Last updated 21 March 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1791 -
Meeting Report: Saving more lives with artesunate injection
On 11 November 2011, the Medicines for Malaria Venture (MMV), World Health Organization (WHO) and Médecins Sans Frontières (MSF), brought together organisations from across the field of malaria to...
Last updated 11 November 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/1781 -
Lives in the balance: The urgent need for HIV and TB treatment in Myanmar
The UN estimates that over the last few years between 15,000 - 20,000 people living with HIV die annually in Myanmar, because of lack of access to urgent lifesaving anti-retroviral therapy (ART).
Last updated 22 February 2012
www.msfaccess.org/our-work/addressing-medical-challenges/article/1765 -
Ten Stories that Mattered in Access to Medicines in 2011
Introduction 2011 marks the ten-year anniversary of two events that have helped shape people’s ability in developing countries to access quality, affordable medical care. First, the signing of...
Last updated 20 December 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/1715
